MET Gene Alterations
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study of TPX-0022 in Patients With Advanced NSCLC, Gastric Cancer or Solid Tumors Harboring Genetic Alterations in MET (NCT03993873) | Turning Point Therapeutics, Inc. | 2019-09-05 |
Track MET Gene Alterations automatically
Every clearance here is in the API, with alerts when new ones post.